Results of two phase 2 studies suggest efgartigimod could be a potential treatment for myositis and Sjögren disease in ...

Y-3 has released limited run of 333 vinyl copies of FW25 Presentation Score titled Y-3002. Produced by electronic duo Soliatry Dancer, the project is also available for digital download on Bandcamp.

NEWARK, Calif. & OSAKA, Japan & CAMBRIDGE, Mass., June 01, 2025--Protagonist Therapeutics, Inc. ("Protagonist") (NASDAQ:PTGX) and Takeda (TSE:4502/NYSE:TAK) announced detailed results from the ...

Shareshot has two new categories of backgrounds too: Solidarity and Stripes. Solidarity has two options styled after the Ukrainian and Palestinian flags, and Stripes includes designs based on LGBTQ+ ...

Learn about grade 3 fatty liver disease, including its symptoms and causes. This article also looks at treatment options, diagnosis, and more.

The Windows Presentation Foundation (WPF, formerly codenamed Avalon) was introduced in .NET Framework 3.0 in 2006 and, like Windows Forms, has also been available in modern .NET since .NET Core 3.0.

Grades: Round 1 • Round 2 • Round 3 • Round 4 • Round 5 • Round 6 • Round 7 65. Giants: Darius Alexander, DT, Toledo Grade: A Ultimate defensive front seven chess piece. Clearly has DT ...

Company News Published 04/24/2025, 10:05 AM 0 Bureau Veritas Q1 2025 presentation: Revenue jumps 8.3%, announces €200M buyback BVI 0.79% ...

Title: Results From VERIFY, a Phase 3, Double-Blind, Placebo (PBO)-Controlled Study of Rusfertide for Treatment of Polycythemia Vera (PV) Abstract: LBA3 Session Name: Plenary Session ...

Protagonist Therapeutics Announces Plenary Presentation on VERIFY Phase 3 Study with Rusfertide at ASCO 2025 NEWARK, CA / ACCESS Newswire / April 23, 2025 / Protagonist Therapeutics, Inc.